Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Improvement of SSRI (selective serotonin re-uptake inhibitors) characteristics, onset of action, responder rate and potential side effect profile. More
Generic dossier More
This invention relates to an animal model showing several behavioral and neuropathological features of schizophrenia. More
Ladostigil, a novel cholinesterase and brain selective monoamine oxidase (MAO) inhibitor for the treatment of dementia co-morbid with depression More
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
"A comprehensive set of samples in various diseases. The resource consists of DNA samples from 16 diseases (Type I diabetes, Type II diabetes, Asthma, Colorectal Cancer, Breast Cancer, Prostate Cancer, Alzheimer's disease, Parkinson's disease... More
Generic dossier More
Technology enable QD product opportunity available for out-license. More
The SNP identified in the SCN1A gene can be used as a genotype test to aid in the correct dosing of anti-epileptic drugs thereby avoiding debilitating adverse drug effects. More
Generic dossier More
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Addiction
- Alcoholism
- Anorexia nervosa
- Anxiety
- Bipolar disorder
- Bulimia nervosa
- Cocaine addiction
- Depression
- Mental health (other)
- Obsessive compulsive disorder
- Opioid dependency
- Panic disorder
- Phobia, social
- Post-traumatic stress disorder
- Psychosis
- Schizophrenia
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us